HomeBALPHARMA • NSE
add
Bal Pharma Ltd
Previous close
₹100.04
Day range
₹99.05 - ₹101.97
Year range
₹78.06 - ₹157.98
Market cap
1.59B INR
Avg Volume
31.34K
P/E ratio
22.02
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 818.76M | -13.47% |
Operating expense | 324.43M | 20.90% |
Net income | 67.34M | 23.04% |
Net profit margin | 8.22 | 42.21% |
Earnings per share | — | — |
EBITDA | 78.93M | -21.51% |
Effective tax rate | -72.56% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 105.18M | -47.22% |
Total assets | 3.36B | 5.06% |
Total liabilities | 2.58B | 3.21% |
Total equity | 774.04M | — |
Shares outstanding | 19.81M | — |
Price to book | 2.56 | — |
Return on assets | 4.07% | — |
Return on capital | 5.97% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 67.34M | 23.04% |
Cash from operations | 44.08M | — |
Cash from investing | 13.63M | — |
Cash from financing | -65.00M | — |
Net change in cash | -1.20M | — |
Free cash flow | -4.67M | — |
About
Founded
1987
Website
Employees
868
